Activators of Nrf2 Translation in Alzheimer's Disease
阿尔茨海默病中 Nrf2 翻译的激活剂
基本信息
- 批准号:9267399
- 负责人:
- 金额:$ 7.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-05-01 至 2019-04-30
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer disease preventionAlzheimer&aposs DiseaseAmyloid beta-ProteinAntioxidantsBiological AssayBiosensorBrainCell LineDepositionDrug Metabolic DetoxicationElementsEnhancersEnzymesGene ExpressionGenesGoalsKnowledgeLibrariesMediatingMusNeurodegenerative DisordersNeurofibrillary TanglesNeuronsOpen Reading FramesOxidative StressPharmacologyPhasePlayProductionPropertyProteinsReportingRoleStructureSynapsesSystemTestingTherapeuticTranslationsantioxidant enzymebasecytotoxicitydesigndisorder preventionextracellularin vivoneuroprotectionnovelnuclear factor-erythroid 2oxidative damagepharmacophorepreventpublic health relevanceresponsescreeningsensorsmall moleculetranscription factor
项目摘要
DESCRIPTION (provided by applicant): This study is designed to screen potent activators of nuclear factor-erythroid 2 related factor 2 (Nrf2) translation for the treatment or prevention of Alzheimer's disease (AD). Nrf2 regulates the expression of most genes involved with the intrinsic antioxidant response and it has been widely reported with in vivo studies, that activatio of this transcription factor has the potential to ameliorate the progression of Alzheimer's disease. Most known activators of Nrf2 act indirectly by preventing its cytoplasmic degradation mediated by Kelch like ECH-associated protein 1 (Keap1). We recently found a novel regulatory mechanism of Nrf2 at the level of protein translation, and were able to create a biosensor to detect activators of Nrf2 translation. We propose testing this sensor to detect Nrf2 translational activators in 5040 natural-derived compounds library. After screening a library using this assay, those compounds found to activate Nrf2 translation will be examined in secondary screen for anti-AD activity. Our aim is to identify novel compounds that activate Nrf2 in cells lines involved
with AD.
描述(由适用提供):本研究旨在筛选核因子 - 刺2相关因子2(NRF2)翻译的潜在激活剂,以治疗或预防阿尔茨海默氏病(AD)。 NRF2调节大多数与内在抗氧化剂反应有关的基因的表达,并且通过体内研究已广泛报道,该转录因子的活化有可能改善阿尔茨海默氏病的进展。 NRF2的最著名活化剂通过防止kelch介导的ECH相关蛋白1(KEAP1)介导的细胞质降解而间接起作用。我们最近在蛋白质翻译水平上发现了NRF2的新调节机制,并能够创建一个生物传感器来检测NRF2翻译的激活剂。我们建议对该传感器进行测试,以检测5040个天然衍生化合物库中的NRF2翻译激活剂。使用此测定法筛选库后,将在二级屏幕中检查发现激活NRF2翻译的这些化合物是否进行抗AD活性。我们的目的是识别激活涉及细胞系中NRF2的新型化合物
与广告。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SALIM MERALI其他文献
SALIM MERALI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SALIM MERALI', 18)}}的其他基金
Adipose Tissue Carbonylome and Sustained Calorie Restriction
脂肪组织羰基化和持续热量限制
- 批准号:
9807394 - 财政年份:2019
- 资助金额:
$ 7.8万 - 项目类别:
Detection of Novel Polyamine Analogs with Anti-Prostate Cancer Activity
具有抗前列腺癌活性的新型多胺类似物的检测
- 批准号:
8525356 - 财政年份:2012
- 资助金额:
$ 7.8万 - 项目类别:
Detection of Novel Polyamine Analogs with Anti-Prostate Cancer Activity
具有抗前列腺癌活性的新型多胺类似物的检测
- 批准号:
8385709 - 财政年份:2012
- 资助金额:
$ 7.8万 - 项目类别:
The Unfolded Protein Response in Human Airway and Alveolar Epithelial Cells
人类气道和肺泡上皮细胞中未折叠的蛋白质反应
- 批准号:
7713872 - 财政年份:2009
- 资助金额:
$ 7.8万 - 项目类别:
The Unfolded Protein Response in Human Airway and Alveolar Epithelial Cells
人类气道和肺泡上皮细胞中未折叠的蛋白质反应
- 批准号:
7837633 - 财政年份:2009
- 资助金额:
$ 7.8万 - 项目类别:
S-Adenosylmethionine and Pneumocystis treatment
S-腺苷甲硫氨酸和肺孢子虫治疗
- 批准号:
7122212 - 财政年份:2004
- 资助金额:
$ 7.8万 - 项目类别:
S-Adenosylmethionine and Pneumocystis treatment
S-腺苷甲硫氨酸和肺孢子虫治疗
- 批准号:
7532766 - 财政年份:2004
- 资助金额:
$ 7.8万 - 项目类别:
S-Adenosylmethionine and Pneumocystis treatment
S-腺苷甲硫氨酸和肺孢子虫治疗
- 批准号:
7322500 - 财政年份:2004
- 资助金额:
$ 7.8万 - 项目类别:
S-Adenosylmethionine and Pneumocystis treatment
S-腺苷甲硫氨酸和肺孢子虫治疗
- 批准号:
7151923 - 财政年份:2004
- 资助金额:
$ 7.8万 - 项目类别:
S-Adenosylmethionine and Pneumocystis treatment
S-腺苷甲硫氨酸和肺孢子虫治疗
- 批准号:
6893248 - 财政年份:2004
- 资助金额:
$ 7.8万 - 项目类别:
相似海外基金
Project 2: Biomarker Analysis, Non-Genetic Risk Factors, and Their Genetic Interactions
项目 2:生物标志物分析、非遗传风险因素及其遗传相互作用
- 批准号:
10555697 - 财政年份:2023
- 资助金额:
$ 7.8万 - 项目类别:
Nursing homes' visitation bans during the COVID-19 pandemic: Effectiveness and consequences.
COVID-19 大流行期间疗养院的探视禁令:有效性和后果。
- 批准号:
10635829 - 财政年份:2023
- 资助金额:
$ 7.8万 - 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 7.8万 - 项目类别:
Innovative Chair to Prevent Pressure Injuries in Persons Living with Alzheimer's Disease and Related Dementias
预防阿尔茨海默病和相关痴呆症患者压力损伤的创新椅子
- 批准号:
10760048 - 财政年份:2023
- 资助金额:
$ 7.8万 - 项目类别:
Investigating Parkin-mediated Neuronal Energy Maintenance in Methamphetamine Use Disorder
研究甲基苯丙胺使用障碍中 Parkin 介导的神经元能量维持
- 批准号:
10736697 - 财政年份:2023
- 资助金额:
$ 7.8万 - 项目类别: